Literature DB >> 29715484

B cell MHC class II signaling: A story of life and death.

Divya Sai Katikaneni1, Lei Jin2.   

Abstract

MHC class II regulates B cell activation, proliferation, and differentiation during cognate B cell-T cell interaction. This is, in part, due to the MHC class II signaling in B cells. Activation of MHC Class II in human B cells or "primed" murine B cells leads to tyrosine phosphorylation, calcium mobilization, AKT, ERK, JNK activation. In addition, crosslinking MHC class II with monoclonal Abs kill malignant human B cells. Several humanized anti-HLA-DR/MHC class II monoclonal Abs entered clinical trials for lymphoma/leukemia and MHC class II-expressing melanomas. Mechanistically, MHC class II is associated with a wealth of transmembrane proteins including the B cell-specific signaling proteins CD79a/b, CD19 and a group of four-transmembrane proteins including tetraspanins and the apoptotic protein MPYS/STING. Furthermore, MHC class II signals are compartmentalized in the tetraspanin-enriched microdomains. In this review, we discuss our current understanding of MHC class II signaling in B cells focusing on its physiological significance and the therapeutic potential. Published by Elsevier Inc.

Entities:  

Keywords:  B cells; CD79a/b; MHC class II; MPYS

Mesh:

Substances:

Year:  2018        PMID: 29715484      PMCID: PMC6207480          DOI: 10.1016/j.humimm.2018.04.013

Source DB:  PubMed          Journal:  Hum Immunol        ISSN: 0198-8859            Impact factor:   2.850


  81 in total

1.  Early biochemical events after MHC class II-mediated signaling on human B lymphocytes.

Authors:  N A Mooney; C Grillot-Courvalin; C Hivroz; L Y Ju; D Charron
Journal:  J Immunol       Date:  1990-10-01       Impact factor: 5.422

2.  SCIMP, a transmembrane adaptor protein involved in major histocompatibility complex class II signaling.

Authors:  Peter Draber; Ivana Vonkova; Ondrej Stepanek; Matous Hrdinka; Marketa Kucova; Tereza Skopcova; Pavel Otahal; Pavla Angelisova; Vaclav Horejsi; Mandy Yeung; Arthur Weiss; Tomas Brdicka
Journal:  Mol Cell Biol       Date:  2011-09-19       Impact factor: 4.272

3.  Selective in vivo antitumor effects of monoclonal anti-I-A antibody on B cell lymphoma.

Authors:  S H Bridges; A M Kruisbeek; D L Longo
Journal:  J Immunol       Date:  1987-12-15       Impact factor: 5.422

4.  HLA class II-mediated death is induced via Fas/Fas ligand interactions in human splenic B lymphocytes.

Authors:  J P Truman; C Choqueux; J Tschopp; J Vedrenne; F Le Deist; D Charron; N Mooney
Journal:  Blood       Date:  1997-03-15       Impact factor: 22.113

5.  TCR-induced transmembrane signaling by peptide/MHC class II via associated Ig-alpha/beta dimers.

Authors:  P Lang; J C Stolpa; B A Freiberg; F Crawford; J Kappler; A Kupfer; J C Cambier
Journal:  Science       Date:  2001-02-23       Impact factor: 47.728

6.  Agonist-Mediated Activation of STING Induces Apoptosis in Malignant B Cells.

Authors:  Chih-Hang Anthony Tang; Joseph A Zundell; Sujeewa Ranatunga; Cindy Lin; Yulia Nefedova; Juan R Del Valle; Chih-Chi Andrew Hu
Journal:  Cancer Res       Date:  2016-03-07       Impact factor: 12.701

7.  CD40 ligand-transduced co-stimulation of T cells in the development of helper function.

Authors:  D van Essen; H Kikutani; D Gray
Journal:  Nature       Date:  1995-12-07       Impact factor: 49.962

8.  Lipid raft-dependent and -independent signaling through HLA-DR molecules.

Authors:  Marlene Bouillon; Youssef El Fakhry; Julie Girouard; Hayssam Khalil; Jacques Thibodeau; Walid Mourad
Journal:  J Biol Chem       Date:  2002-12-22       Impact factor: 5.157

9.  The CD19/CD81 complex physically interacts with CD38 but is not required to induce proliferation in mouse B lymphocytes.

Authors:  Felipe Vences-Catalán; Ranjani Rajapaksa; Shoshana Levy; Leopoldo Santos-Argumedo
Journal:  Immunology       Date:  2012-09       Impact factor: 7.397

10.  Intrinsic antiproliferative activity of the innate sensor STING in T lymphocytes.

Authors:  Silvia Cerboni; Nadia Jeremiah; Matteo Gentili; Ulf Gehrmann; Cécile Conrad; Marie-Claude Stolzenberg; Capucine Picard; Bénédicte Neven; Alain Fischer; Sébastian Amigorena; Frédéric Rieux-Laucat; Nicolas Manel
Journal:  J Exp Med       Date:  2017-05-08       Impact factor: 14.307

View more
  6 in total

1.  Comprehensive Characterizations of Immune Receptor Repertoire in Tumors and Cancer Immunotherapy Studies.

Authors:  Li Song; Zhangyi Ouyang; David Cohen; Yang Cao; Jennifer Altreuter; Gali Bai; Xihao Hu; Kenneth J Livak; Heng Li; Ming Tang; Bo Li; X Shirley Liu
Journal:  Cancer Immunol Res       Date:  2022-07-01       Impact factor: 12.020

2.  DNA methylation and gene expression signatures are associated with ataxia-telangiectasia phenotype.

Authors:  Sharon A McGrath-Morrow; Roland Ndeh; Kathryn A Helmin; Basil Khuder; Cynthia Rothblum-Oviatt; Joseph M Collaco; Jennifer Wright; Paul A Reyfman; Howard M Lederman; Benjamin D Singer
Journal:  Sci Rep       Date:  2020-05-04       Impact factor: 4.379

3.  Multi-Omics Resolves a Sharp Disease-State Shift between Mild and Moderate COVID-19.

Authors:  Yapeng Su; Daniel Chen; Dan Yuan; Christopher Lausted; Jongchan Choi; Chengzhen L Dai; Valentin Voillet; Venkata R Duvvuri; Kelsey Scherler; Pamela Troisch; Priyanka Baloni; Guangrong Qin; Brett Smith; Sergey A Kornilov; Clifford Rostomily; Alex Xu; Jing Li; Shen Dong; Alissa Rothchild; Jing Zhou; Kim Murray; Rick Edmark; Sunga Hong; John E Heath; John Earls; Rongyu Zhang; Jingyi Xie; Sarah Li; Ryan Roper; Lesley Jones; Yong Zhou; Lee Rowen; Rachel Liu; Sean Mackay; D Shane O'Mahony; Christopher R Dale; Julie A Wallick; Heather A Algren; Michael A Zager; Wei Wei; Nathan D Price; Sui Huang; Naeha Subramanian; Kai Wang; Andrew T Magis; Jenn J Hadlock; Leroy Hood; Alan Aderem; Jeffrey A Bluestone; Lewis L Lanier; Philip D Greenberg; Raphael Gottardo; Mark M Davis; Jason D Goldman; James R Heath
Journal:  Cell       Date:  2020-10-28       Impact factor: 41.582

Review 4.  Reverse Signaling by MHC-I Molecules in Immune and Non-Immune Cell Types.

Authors:  Elke M Muntjewerff; Luca D Meesters; Geert van den Bogaart; Natalia H Revelo
Journal:  Front Immunol       Date:  2020-12-15       Impact factor: 7.561

5.  Flow Cytometric Analysis of Leukocyte Populations in the Lung Tissue of Dromedary Camels.

Authors:  Jamal Hussen; Turke Shawaf; Naser Abdallah Al Humam; Sameer M Alhojaily; Mohammed Ali Al-Sukruwah; Faisal Almathen; Francesco Grandoni
Journal:  Vet Sci       Date:  2022-06-10

6.  B Cells Improve Overall Survival in HPV-Associated Squamous Cell Carcinomas and Are Activated by Radiation and PD-1 Blockade.

Authors:  Sangwoo S Kim; Sarek Shen; Sayuri Miyauchi; P Dominick Sanders; Ida Franiak-Pietryga; Loren Mell; J Silvio Gutkind; Ezra E W Cohen; Joseph A Califano; Andrew B Sharabi
Journal:  Clin Cancer Res       Date:  2020-03-19       Impact factor: 13.801

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.